Goldenwell Biotech (GWLL) Shares Outstanding (Weighted Average) (2019 - 2025)

Goldenwell Biotech has reported Shares Outstanding (Weighted Average) for 7 years, with the latest figure at $99.0 million in Q3 2025.

• For the quarter ending Q3 2025, Shares Outstanding (Weighted Average) rose 2.66% year-over-year to $99.0 million; the trailing twelve-month figure through Sep 2025 stood at $99.0 million (up 2.66% YoY), and the FY2024 full-year result was $99.0 million, up 2.66% from the prior year.
• Shares Outstanding (Weighted Average) for Q3 2025 stood at $99.0 million, up from $9.9 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $99.0 million in Q4 2024, with the low at $9.9 million in Q1 2025.
• Historically, Shares Outstanding (Weighted Average) has averaged $85.1 million across 5 years, with a median of $96.4 million in 2022.
• Annual changes were most pronounced in 2021 — Shares Outstanding (Weighted Average) advanced 14.15% — and 2025, when it slumped 89.73%.
• Goldenwell Biotech's Shares Outstanding (Weighted Average) stood at $91.3 million in 2021, then increased by 5.6% to $96.4 million in 2022, then changed by 0.0% to $96.4 million in 2023, then rose by 2.66% to $99.0 million in 2024, then changed by 0.0% to $99.0 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $99.0 million (Q3 2025), $9.9 million (Q2 2025), and $9.9 million (Q1 2025), per Business Quant data.